(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

REEVE FOUNDATION NORTH AMERICAN CLINICAL TRIALS NETWORK

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

REEVE FOUNDATION NORTH AMERICAN CLINICAL TRIALS NETWORK

ST13

US500000077669997

Class

44

Filing

77669997

Registration

3800543

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

49

Latest update

04/08/2026

Trademark type

Combined

Nice classes

44

Filing date

02/13/2009

Registration date

06/08/2010

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/24/2020

Last transaction

04/08/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/01/2008

First use in commerce

09/01/2008

Drawing code

3

Owner type

99

Owner location

Short Hills, NJ, US

Examiner

DE JONGE, KATHLEEN

Law office

L70

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of the words "REEVE FOUNDATION NORTH AMERICAN CLINICAL TRIALS NETWORK", printed in capital letters; the words "Reeve Foundation", in orange letters, printed above the words "North American", in gray letters, printed above the words "Clinical Trials Network", in gray letters, and the colors red, yellow, and orange appearing in the two wavy, flag-like designs; the red shape overlaps the yellow shape, which is orange in color on the upper left side.

Holders and representatives

Holders

Christopher Reeve Foundation, a New Jersey Nonprofit Corporation

Representatives

Henry Lebowitz, Esq. DEBEVOISE & PLIMPTON LLP

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Providing treatments for participants in clinical trials of therapies for spinal cord injuries

Publications

History of USPTO decisions and trademark events.

49 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/06/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/06/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/06/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/06/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/06/2026

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

06/06/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/06/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/06/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/06/2023

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/24/2020

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

09/24/2020

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/24/2020

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

09/17/2020

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

08/09/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/04/2020

E89R

TEAS SECTION 8 & 9 RECEIVED

06/04/2020

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/08/2019

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

11/16/2015

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/16/2015

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/16/2015

E815

TEAS SECTION 8 & 15 RECEIVED

09/25/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

06/08/2010

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED

05/07/2010

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

05/06/2010

ALIE

ASSIGNED TO LIE

05/06/2010

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

04/27/2010

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED

04/20/2010

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/19/2010

EX1G

SOU EXTENSION 1 GRANTED

04/19/2010

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/19/2010

IUAF

USE AMENDMENT FILED

03/25/2010

EXT1

SOU EXTENSION 1 FILED

03/25/2010

EEXT

SOU TEAS EXTENSION RECEIVED

03/25/2010

EISU

TEAS STATEMENT OF USE RECEIVED

03/25/2010

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

10/13/2009

PUBO

PUBLISHED FOR OPPOSITION

07/21/2009

NPUB

NOTICE OF PUBLICATION

07/01/2009

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

06/16/2009

ALIE

ASSIGNED TO LIE

06/16/2009

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/12/2009

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/11/2009

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/11/2009

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/11/2009

CNRT

NON-FINAL ACTION MAILED

05/07/2009

CNRT

NON-FINAL ACTION WRITTEN

05/06/2009

DOCK

ASSIGNED TO EXAMINER

05/05/2009

MDSC

NOTICE OF DESIGN SEARCH CODE MAILED

02/19/2009

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/18/2009

NWAP

NEW APPLICATION ENTERED

02/17/2009

Continuous trademark protection

Get notified about every new filing that threatens REEVE FOUNDATION NORTH AMERICAN CLINICAL TRIALS NETWORK or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.